UFIS-SWE-IG
0.1.0 - ci-build

UFIS-SWE-IG, published by UNICOM. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/joofio/ufis-swe-ig/ and changes regularly. See the Directory of published versions

Example MedicinalProductDefinition: AnafranilRet-75mg-Tablet-SE-IS-MPD

Generated Narrative: MedicinalProductDefinition AnafranilRet-75mg-Tablet-SE-IS-MPD

identifier: http://ema.europa.eu/fhir/mpId/SE-100012657-00010568, http://ema.europa.eu/fhir/eurdId/811

domain: Human use

status: Current

combinedPharmaceuticalDoseForm: Prolonged-release tablet

indication:

Egentlig depression med melankoli. Djupa eller långvariga egentliga depressioner utan melankoli. Paniksyndrom med eller utan agorafobi. Agorafobi. Tvångstillstånd. Associerade symtom vid narkolepsi (speciellt kataplexi, sömnparalys och hypnagoga hallucinationer). Idiopatiskt smärtsyndrom med depressiva symtom.

legalStatusOfSupply: Medicinal product subject to medical prescription

classification: N06AA04

name

productName: Anafranil® Retard 75 mg Depottablett

part

part: Anafranil® Retard

type: Invented name part

part

part: 75 mg

type: Strength part

part

part: Depottablett

type: Pharmaceutical dose form part

Usages

-CountryLanguage
*Kingdom of SwedenSwedish

Characteristics

-Type
*Depottablett